Medicare News
Medicare GLP-1 Coverage in 2026 and Beyond
GLP-1 drugs (Ozempic, Wegovy, and Zepbound) treat conditions like Type 2 diabetes, heart disease, and obesity. These medications are well-known for their effectiveness, but they’re also notorious for their high cost. Without insurance, the drugs can cost upwards of $1,300 a month and are often taken long-term. While most insurance covers GLP-1s for diabetes and…
Read MorePre-Authorization for Medicare: What to Know in 2026
Pre-authorization, sometimes referred to as prior authorization, is the approval healthcare providers require from insurance carriers before delivering certain services or prescriptions to patients. While you can still get the service without pre-authorization, you’ll be responsible for the full cost. Also, prior authorization approval doesn’t guarantee coverage. The waiting and uncertainty of the process can…
Read More